List of Excipients in API acetaminophen, asprin, caffeine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing acetaminophen, asprin, caffeine
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Haleon US Holdings LLC | EXCEDRIN | acetaminophen, asprin, caffeine | 0067-2035 | BENZOIC ACID | |
| Haleon US Holdings LLC | EXCEDRIN | acetaminophen, asprin, caffeine | 0067-2035 | CELLULOSE, MICROCRYSTALLINE | |
| Haleon US Holdings LLC | EXCEDRIN | acetaminophen, asprin, caffeine | 0067-2035 | D&C YELLOW NO. 10 | |
| Haleon US Holdings LLC | EXCEDRIN | acetaminophen, asprin, caffeine | 0067-2035 | DIMETHICONE | |
| Haleon US Holdings LLC | EXCEDRIN | acetaminophen, asprin, caffeine | 0067-2035 | EDETATE DISODIUM ANHYDROUS | |
| Haleon US Holdings LLC | EXCEDRIN | acetaminophen, asprin, caffeine | 0067-2035 | FD&C BLUE NO. 1 | |
| Haleon US Holdings LLC | EXCEDRIN | acetaminophen, asprin, caffeine | 0067-2035 | FD&C RED NO. 40 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for acetaminophen, asprin, caffeine
Excipient focus: BENZOIC ACID
acetaminophen, asprin, caffeine drug variants containing BENZOIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | acetaminophen, asprin, caffeine | 0067-2035 |
| >Company | >Ingredient | >NDC |
acetaminophen, asprin, caffeine drug variants not containing BENZOIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
acetaminophen, asprin, caffeine drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | acetaminophen, asprin, caffeine | 0067-2035 |
| >Company | >Ingredient | >NDC |
acetaminophen, asprin, caffeine drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
acetaminophen, asprin, caffeine drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | acetaminophen, asprin, caffeine | 0067-2035 |
| >Company | >Ingredient | >NDC |
acetaminophen, asprin, caffeine drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: DIMETHICONE
acetaminophen, asprin, caffeine drug variants containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | acetaminophen, asprin, caffeine | 0067-2035 |
| >Company | >Ingredient | >NDC |
acetaminophen, asprin, caffeine drug variants not containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM ANHYDROUS
acetaminophen, asprin, caffeine drug variants containing EDETATE DISODIUM ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | acetaminophen, asprin, caffeine | 0067-2035 |
| >Company | >Ingredient | >NDC |
acetaminophen, asprin, caffeine drug variants not containing EDETATE DISODIUM ANHYDROUS
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
acetaminophen, asprin, caffeine drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | acetaminophen, asprin, caffeine | 0067-2035 |
| >Company | >Ingredient | >NDC |
acetaminophen, asprin, caffeine drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
acetaminophen, asprin, caffeine drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | acetaminophen, asprin, caffeine | 0067-2035 |
| >Company | >Ingredient | >NDC |
acetaminophen, asprin, caffeine drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
acetaminophen, asprin, caffeine drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | acetaminophen, asprin, caffeine | 0067-2035 |
| >Company | >Ingredient | >NDC |
acetaminophen, asprin, caffeine drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
acetaminophen, asprin, caffeine drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | acetaminophen, asprin, caffeine | 0067-2035 |
| >Company | >Ingredient | >NDC |
acetaminophen, asprin, caffeine drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
acetaminophen, asprin, caffeine drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | acetaminophen, asprin, caffeine | 0067-2035 |
| >Company | >Ingredient | >NDC |
acetaminophen, asprin, caffeine drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
acetaminophen, asprin, caffeine drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | acetaminophen, asprin, caffeine | 0067-2035 |
| >Company | >Ingredient | >NDC |
acetaminophen, asprin, caffeine drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
acetaminophen, asprin, caffeine drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | acetaminophen, asprin, caffeine | 0067-2035 |
| >Company | >Ingredient | >NDC |
acetaminophen, asprin, caffeine drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
acetaminophen, asprin, caffeine drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | acetaminophen, asprin, caffeine | 0067-2035 |
| >Company | >Ingredient | >NDC |
acetaminophen, asprin, caffeine drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
acetaminophen, asprin, caffeine drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | acetaminophen, asprin, caffeine | 0067-2035 |
| >Company | >Ingredient | >NDC |
acetaminophen, asprin, caffeine drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LIGHT MINERAL OIL
acetaminophen, asprin, caffeine drug variants containing LIGHT MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | acetaminophen, asprin, caffeine | 0067-2035 |
| >Company | >Ingredient | >NDC |
acetaminophen, asprin, caffeine drug variants not containing LIGHT MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MALTITOL
acetaminophen, asprin, caffeine drug variants containing MALTITOL
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | acetaminophen, asprin, caffeine | 0067-2035 |
| >Company | >Ingredient | >NDC |
acetaminophen, asprin, caffeine drug variants not containing MALTITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
acetaminophen, asprin, caffeine drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | acetaminophen, asprin, caffeine | 0067-2035 |
| >Company | >Ingredient | >NDC |
acetaminophen, asprin, caffeine drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PEPSIN
acetaminophen, asprin, caffeine drug variants containing PEPSIN
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | acetaminophen, asprin, caffeine | 0067-2035 |
| >Company | >Ingredient | >NDC |
acetaminophen, asprin, caffeine drug variants not containing PEPSIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 20
acetaminophen, asprin, caffeine drug variants containing POLYSORBATE 20
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | acetaminophen, asprin, caffeine | 0067-2035 |
| >Company | >Ingredient | >NDC |
acetaminophen, asprin, caffeine drug variants not containing POLYSORBATE 20
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
acetaminophen, asprin, caffeine drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | acetaminophen, asprin, caffeine | 0067-2035 |
| >Company | >Ingredient | >NDC |
acetaminophen, asprin, caffeine drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYL GALLATE
acetaminophen, asprin, caffeine drug variants containing PROPYL GALLATE
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | acetaminophen, asprin, caffeine | 0067-2035 |
| >Company | >Ingredient | >NDC |
acetaminophen, asprin, caffeine drug variants not containing PROPYL GALLATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
acetaminophen, asprin, caffeine drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | acetaminophen, asprin, caffeine | 0067-2035 |
| >Company | >Ingredient | >NDC |
acetaminophen, asprin, caffeine drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
acetaminophen, asprin, caffeine drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | acetaminophen, asprin, caffeine | 0067-2035 |
| >Company | >Ingredient | >NDC |
acetaminophen, asprin, caffeine drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITAN MONOLAURATE
acetaminophen, asprin, caffeine drug variants containing SORBITAN MONOLAURATE
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | acetaminophen, asprin, caffeine | 0067-2035 |
| >Company | >Ingredient | >NDC |
acetaminophen, asprin, caffeine drug variants not containing SORBITAN MONOLAURATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
acetaminophen, asprin, caffeine drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | acetaminophen, asprin, caffeine | 0067-2035 |
| >Company | >Ingredient | >NDC |
acetaminophen, asprin, caffeine drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
acetaminophen, asprin, caffeine drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Haleon US Holdings LLC | acetaminophen, asprin, caffeine | 0067-2035 |
| >Company | >Ingredient | >NDC |
acetaminophen, asprin, caffeine drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
